Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial

✍ Scribed by Rini, Brian I; Melichar, Bohuslav; Ueda, Takeshi; Grünwald, Viktor; Fishman, Mayer N; Arranz, José A; Bair, Angel H; Pithavala, Yazdi K; Andrews, Glen I; Pavlov, Dmitri; Kim, Sinil; Jonasch, Eric

• Book ID: 122128375
• Publisher: The Lancet
• Year: 2013
• Tongue: English
• Weight: 244 KB
• Volume: 14
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/S1470-2045(13)70464-9